Diverse molecular forms of plasma B-type natriuretic peptide in heart failure

Current Heart Failure Reports

Volumn 8, Issue 2, 2011, Pages 140-146

  Nishikimi, Toshio ^a   Minamino, Naoto ^b   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Atrial natriuretic peptide; Atrial overload; B type natriuretic peptide; BNP 32; cGMP; Cyclic guanosine monophosphate; Gel filtration; Heart failure; Molecular form; Natriuretic peptide receptor A; O glycosylation; ProBNP 108; Processing; Secretion; Ventricular overload

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP; FIBROBLAST GROWTH FACTOR; MESSENGER RNA; VASCULAR ENDOTHELIAL GROWTH INHIBITOR;

AMINO ACID ANALYSIS; AORTA STENOSIS; ARTICLE; BLOOD SAMPLING; GLYCOSYLATION; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART VENTRICLE OVERLOAD; HEAT STRESS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MOLECULAR PATHOLOGY; PATHOPHYSIOLOGY; PERICARDIAL EFFUSION; PROTEIN DEGRADATION;

BIOLOGICAL MARKERS; HEART FAILURE; HUMANS; NATRIURETIC PEPTIDE, BRAIN;

EID: 79957456283     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-011-0051-y     Document Type: Article

References (25)

1. Minamino N, Horio H, Nishikimi T: Chapter 165. Natriuretic peptides in the cardiovascular system. In: Kastin AJ, editor. THE HANDBOOK OF BIOLOGICALLY ACTIVE PEPTIDES. Academic Press; 2006. p. 1217-1225.
2. T Sudoh K Kangawa N Minamino H Matsuo 1988 A new natriuretic peptide in porcine brain Nature. 332 78 81 2964562 10.1038/332078a0 1:CAS:528: DyaL1cXitFKru7o%3D (Pubitemid 18083551)
3. T Nishikimi N Maeda H Matsuoka 2006 The role of natriuretic peptides in cardioprotection Cardiovasc Res. 69 318 328 16289003 10.1016/j.cardiores.2005. 10.001 1:CAS:528:DC%2BD28Xls1Wrug%3D%3D (Pubitemid 43098788)
4. LB Daniels AS Maisel 2007 Natriuretic peptides J Am Coll Cardiol. 50 2357 2368 18154959 10.1016/j.jacc.2007.09.021 1:CAS:528:DC%2BD2sXhsVOrtL7O (Pubitemid 50011582)
5. M Weber C Hamm 2006 Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine Heart. 92 843 849 16698841 10.1136/hrt.2005.071233 1:CAS:528:DC%2BD28XlvVSktrg%3D (Pubitemid 43799232)
6. CS Lam JC Burnett Jr L Costello-Boerrigter, et al. 2007 Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population J Am Coll Cardiol. 49 1193 1202 17367664 10.1016/j.jacc.2006.12.024 1:CAS:528:DC%2BD2sXjtVagu74%3D (Pubitemid 46400332)
7. SW Waldo J Beede S Isakson, et al. 2008 Pro-B-type natriuretic peptide levels in acute decompensated heart failure J Am Coll Cardiol. 51 1874 1882 18466803 10.1016/j.jacc.2007.12.051 1:CAS:528:DC%2BD1cXlslOrsb0%3D (Pubitemid 351615249)
8. KR Seferian NN Tamm AG Semenov, et al. 2007 The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure Clin Chem. 53 866 873 17384012 10.1373/clinchem.2006.076141 1:CAS:528:DC%2BD2sXltFyqtrg%3D (Pubitemid 46744242)
9. H Shimizu K Masuta H Asada, et al. 2003 Characterization of molecular forms of probrain natriuretic peptide in human plasma Clin Chim Acta. 334 233 239 12867297 10.1016/S0009-8981(03)00240-7 1:CAS:528:DC%2BD3sXlsVWqur4%3D (Pubitemid 36836080)
10. T Nishikimi N Minamino K Horii H Matsuoka 2007 Do commercially available assay kits for B-type natriuretic peptide measure Pro-BNP1-108, as well as BNP1-32? Hypertension. 50 e163 17875817 10.1161/HYPERTENSIONAHA.107.098350 1:CAS:528:DC%2BD1cXjslCisA%3D%3D (Pubitemid 350287552)
11. F Liang J O'Rear U Schellenberger, et al. 2007 Evidence for functional heterogeneity of circulating B-type natriuretic peptide J Am Coll Cardiol. 49 1071 1078 17349887 10.1016/j.jacc.2006.10.063 1:CAS:528:DC%2BD2sXivVams7s%3D (Pubitemid 46349497)
12. U Schellenberger J O'Rear A Guzzetta, et al. 2006 The precursor to B-type natriuretic peptide is an O-linked glycoprotein Arch Biochem Biophys. 451 160 166 16750161 10.1016/j.abb.2006.03.028 1:CAS:528:DC%2BD28XmvVaktrs%3D
13. Nishikimi T, Minamino N, Masashi I, et al. Diversity of molecular forms of plasma brain natriuretic peptide in heart failure-different proBNP-108 to BNP-32 ratios in atrial and ventricular overload-Heart. 2010; 96:432-9. This study was the first to show the relation between increase of proBNP-108 and ventricular overload in patients with heart failure.
14. F Yoshihara T Nishikimi Y Sasako, et al. 2002 Plasma atrial natriuretic peptide concentration inversely correlates with left atrial collagen volume fraction in patients with atrial fibrillation: plasma ANP as a possible biochemical marker to predict the outcome of the maze procedure J Am Coll Cardiol. 39 288 294 11788221 10.1016/S0735-1097(01)01719-3 1:CAS:528: DC%2BD38XhtFWqs7w%3D (Pubitemid 34084635)
15. J Hino H Tateyama N Minamino, et al. 1990 Isolation and identification of human brain natriuretic peptides in cardiac atrium Biochem Biophys Res Commun. 167 693 700 2138890 10.1016/0006-291X(90)92081-A 1:CAS:528:DyaK3cXhslejsLs%3D (Pubitemid 20113237)
16. T Nishikimi I Shibasaki H Iida, et al. 2002 Molecular forms of adrenomedullin in pericardial fluid and plasma in patients with ischaemic heart disease Clin Sci (Lond). 102 669 677 10.1042/CS20010236 1:CAS:528: DC%2BD38Xlt1CksL0%3D (Pubitemid 34620900)
17. T Nishikimi H Asakawa H Iida, et al. 2004 Different secretion patterns of two molecular forms of cardiac adrenomedullin in pressure-and volume-overloaded human heart failure J Card Fail. 10 321 327 15309699 10.1016/j.cardfail.2003. 12.002 1:CAS:528:DC%2BD2cXmslOgt74%3D (Pubitemid 39092684)
18. M Fujita M Ikemoto M Kishishita, et al. 1996 Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina Circulation. 94 610 613 8772678 1:STN:280:DyaK28zmvVKksg%3D%3D (Pubitemid 26289212)
19. K Tambara M Fujita N Nagaya, et al. 2002 Increased pericardial fluid concentrations of the mature form of adrenomedullin in patients with cardiac remodelling Heart. 87 242 246 11847163 10.1136/heart.87.3.242 1:CAS:528:DC%2BD38XltFOks7w%3D (Pubitemid 34177679)
20. T Tsutamoto A Wada K Maeda, et al. 1997 Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction Circulation. 96 509 516 9244219 1:STN:280:DyaK2szos1eksg%3D%3D (Pubitemid 27329427)
21. A Hammerer-Lercher B Halfinger B Sarg, et al. 2008 Analysis of circulating forms of proBNP and NT-proBNP in patients with severe heart failure Clin Chem. 54 858 865 18339696 10.1373/clinchem.2007.090266 1:CAS:528: DC%2BD1cXlsVWjurw%3D (Pubitemid 351671596)
22. Semenov AG, Postnikov AB, Tamm NN, et al.: Processing of pro-Brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site. Clin Chem. 2009;55:493-8. This study was the first to show that the O-glycosylation at Thr-71 in a region close to the cleavage site impairs proBNP-108 processing by furin in HEK293 cell.
23. Semenov AG, Tamm NN, Seferian KR, et al.: Processing of pro-B-type natriuretic peptide: furin and corin as candidate convertases. Clin Chem. 2010;56:1166-76. This study shows that both furin and corin are involved in the proBNP processing pathway.
24. KN Luckenbill RH Christenson AS Jaffe, et al. 2008 Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage Clin Chem. 54 619 621 18310156 10.1373/clinchem.2007.097998 1:CAS:528:DC%2BD1cXivVansb0%3D (Pubitemid 351348175)
25. KR Seferian NN Tamm AG Semenov, et al. 2008 Immunodetection of glycosylated NT-proBNP circulating in human blood Clin Chem. 54 866 873 18339697 10.1373/clinchem.2007.100040 1:CAS:528:DC%2BD1cXlsVWjur0%3D (Pubitemid 351671597)